Edition:
United Kingdom

Sientra Inc (SIEN.OQ)

SIEN.OQ on NASDAQ Stock Exchange Global Select Market

13.00USD
18 Jan 2019
Change (% chg)

$-0.20 (-1.52%)
Prev Close
$13.20
Open
$13.23
Day's High
$13.41
Day's Low
$12.94
Volume
102,555
Avg. Vol
120,032
52-wk High
$26.79
52-wk Low
$8.79

Chart for

About

Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 190 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast... (more)

Overall

Beta: --
Market Cap(Mil.): $307.56
Shares Outstanding(Mil.): 19.31
Dividend: --
Yield (%): --

Financials

  SIEN.OQ Industry Sector
P/E (TTM): -- 32.17 33.71
EPS (TTM): -2.66 -- --
ROI: -61.89 13.75 14.48
ROE: -64.43 16.50 15.99

SEC sues U.S. breast-implant company's ex-CEO after stock dive

The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.

19 Sep 2018

UPDATE 1-SEC sues U.S. breast-implant company's ex-CEO after stock dive

Sept 19 The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.

19 Sep 2018

SEC sues ex-CEO of California breast implant company after stock nosedived

Sept 19 The U.S. Securities and Exchange Commission on Wednesday sued the founder and former chief executive of Sientra Inc for fraudulently concealing problems with his company's breast and other implants as it was raising $61.4 million in a public stock offering.

19 Sep 2018

Earnings vs. Estimates